MindWalk Holdings Corp. (HYFT)
About MindWalk Holdings Corp.
MindWalk Holdings Corp is a Bio-Native AI company transforming drug discovery and development. Powered by patented HYFT technology and the LensAI platform, MindWalk unifies sequence, structure, function, and literature into a single computational language and closes the loop with an integrated, full-stack wet lab. The platform supports rapid epitope mapping, de novo molecular design, in silico vaccine exploration, and population-scale biologics analytics that help turn insights into validated candidates at speed.
This profile is unclaimed. An authorized representative can claim it to add details and earn the Verified badge.
Financial summary
- Market cap
- $78.5M
15-minute delayed · data by Polygon.io
Past year · hover for prices
52-week range
- Market cap
- $78.5M
- Shares outstanding
- 57.7M
- Open
- —
- Day range
- –
- Prev close
- —
- Volume
- —
- IPO date
- Jul 16, 2010
MindWalk Holdings Corp. (HYFT) Stock Price
- Trading 51% below its 52-week high.
Automatically generated from public filings and market data. Informational only — not investment advice or a recommendation to buy or sell any security.
No reviews yet. Be the first to review MindWalk Holdings Corp..
Write a review
News about MindWalk Holdings Corp.
News & sentiment via Polygon.io
MindWalk Holdings Corp.: frequently asked questions
Is MindWalk Holdings Corp. an American company?
MindWalk Holdings Corp. is a US-based company, listed in the americancompanies.com directory of American companies. Its American-origin credentials have not yet been independently verified.
Is MindWalk Holdings Corp. publicly traded?
Yes — MindWalk Holdings Corp. is a publicly traded company. Its stock trades under the ticker symbol HYFT on the NASDAQ.
What does MindWalk Holdings Corp. do?
MindWalk Holdings Corp. is an American Pharmaceuticals company in the Health & Beauty sector.
